Google’s DeepMind unit has used its artificial intelligence expertise to catalogue millions of ‘missense’ mutations in human DNA that may be related to the development of
German group Merck has revved up its artificial intelligence-powered drug discovery with partnerships with two UK companies – Exscientia and BenevolentAI – that will focus
After the breakneck pace of development in the digital health category during the pandemic, 2023 looks like it could be a pivotal year, with financing levels falling and t
The Netherlands’ R&D agency TNO has launched a digital health company – AIKON Health – that will focus on the development of wearable devices that will be used to moni
One of the pioneers of the prescription digital therapeutics (DTx) sector, Akili Interactive, has decided to abandon that approach and focus exclusively on a direct-to-con